RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090054366A1
SERIAL NO

12132453

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to the use of short interfering nucleic acid molecules (siRNA) to inhibit Nuclear Mitotic Apparatus Protein (NuMA) gene expression and their use in treatment of disease, including cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RELIANCE LIFE SCIENCES PVT LTDMUMBAI 400 701 MAH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Addepalli, Murali Maharashtra , IN 2 1
Bimalendu, Kriti Ray Maharashtra , IN 2 1
Chandra, Reddy Gopavaram Vidyadhar Eswar Maharashtra , IN 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation